An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease?

Photo by Fusion Medical Animation on Unsplash

Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ:VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. 

Greg discussed Virios Therapeutics’ mission and the clinical-stage company’s ongoing progress in developing innovative antiviral therapies to treat diseases - like fibromyalgia (FM) and related health concerns. 

Watch the full interview here.